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Abstract
 
B cell linker protein (BLNK) and Src homology 2 domain–containing leukocyte protein of 76
kD (SLP-76) are adaptor proteins required for B cell receptor (BCR) and T cell receptor func-
tion, respectively. Here, we show that expression of SLP-76 cannot reconstitute BCR function
 
in Zap-70
 
1
 
BLNK
 
2
 
 B cells. This could be attributable to inability of SLP-76 to be recruited
into glycolipid-enriched microdomains (GEMs) after antigen receptor cross-linking. Support-
ing this idea, the BCR function was restored when a membrane-associated SLP-76 chimera
was enforcedly localized to GEMs. Moreover, we demonstrate that addition of both linker for
activation of T cells (LAT) and Grb2-related adaptor downstream of Shc (Gads) to SLP-76 al-
low SLP-76 to be recruited into GEMs, whereby the BCR function is reconstituted. The Gads
function was able to be replaced by overexpression of Grb2. In contrast to SLP-76, BLNK did
not require Grb2 families for its recruitment to GEMs. Hence, these data suggest a functional
overlap between BLNK and SLP-76, while emphasizing the difference in requirement for ad-
ditional adaptor molecules in their targeting to GEMs.
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Introduction
 
Recent advances in membrane biology have led to the
identification of subdomains of the plasma membrane
 
known as glycolipid-enriched microdomains (GEMs)
 
1
 
 or
detergent-insoluble rafts. This membrane heterogeneity is
caused by the self-association of sphingolipids, cholesterol,
and protein components. GEMs have been proposed to be
involved in membrane trafficking, cell morphogenesis, and
signal transduction mechanisms. Indeed, a variety of signal-
ing molecules are concentrated in GEMs, including Src
family tyrosine kinases and monomeric and heterotrimeric
G proteins, as well as molecules involved in Ca
 
2
 
1
 
 influx
(for reviews, see references 1–3).
Although immune receptors such as B cell receptor
(BCR), TCR, and FcR are not significantly enriched in
the GEMs before stimulation, aggregation of these recep-
tors results in the accumulation of tyrosine-phosphorylated
receptors and signaling molecules in the GEMs (4–10). For
example, after TCR stimulation, Zap-70 translocates from
the cytoplasm to the GEMs, and the tyrosine phosphory-
 
lated phospholipase C (PLC)-
 
g
 
1 becomes enriched within
the GEMs (6, 7, 11). In the case of Fc
 
e
 
RI, biochemical
analysis or direct monitoring in living cells has documented
that after aggregation of Fc
 
e
 
RI, Syk and PLC-
 
g
 
1, in addi-
tion to Fc
 
e
 
RI by itself, are rapidly recruited to the punctate
plasma membrane microdomains, presumably reflecting
GEMs (9, 10). The functional importance of membrane
compartmentation in immune receptor signaling has been
recently suggested by the findings that disruption of GEMs
by the depletion or the sequestration of membrane choles-
terol resulted in attenuation of antigen receptor–mediated
calcium mobilization (5, 7).
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Abbreviations used in this paper:
 
 BCR, B cell receptor; BLNK, B cell
 
linker protein; [Ca
 
2
 
1
 
]
 
i
 
, intracellular Ca
 
2
 
1
 
 concentration; Gads, Grb2-
related adaptor downstream of Shc; GEM, glycolipid-enriched micro-
 
domain; HA, hemagglutinin; IP
 
3
 
, inositol 1,4,5-trisphosphate; JNK, c-Jun
NH
 
2
 
-terminal kinase; LAT, linker for activation of T cells; PLC, phos-
pholipase C; PTK, protein tyrosine kinase; SH, Src homology; SLP-76,
Src homology 2 domain–containing leukocyte protein of 76 kD. 
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Linker for activation of T cells (LAT) could provide the
molecular basis by which signaling molecules are accumu-
lated into GEMs upon engagement of TCR (12, 13). LAT
is palmitoylated and is localized in GEMs before TCR liga-
tion (11, 14). Once LAT is tyrosine phosphorylated by
Zap-70, critical downstream signaling molecules are subse-
quently bound to the phosphorylated LAT, either directly
or indirectly (12, 13, 15, 16). One of the associated mole-
cules is Src homology (SH)2 domain–containing leukocyte
protein of 76 kD (SLP-76), tyrosine phosphorylation of
which requires LAT (15–17). Because Grb2 is able to bind
to the tyrosine-phosphorylated LAT and the proline-rich
region of SLP-76 by using its SH2 and SH3 domains, re-
spectively, it was initially thought that Grb2 might act as a
bridge between LAT and SLP-76. However, as a recently
cloned Grb2-like adaptor protein, Grb2-related adaptor
downstream of Shc (Gads; alternatively named as Grf40 or
GrpL) was found to bind to SLP-76 more tightly than does
Grb2, it has been proposed that Gads rather than Grb2
might connect phosphorylated LAT to SLP-76 in TCR
signaling (18–20).
In contrast to expression of SLP-76 in T cells, NK cells,
mast cells, macrophages, and platelets, B cell linker protein
(BLNK; alternatively named as SLP-65, B cell adaptor con-
taining SH2 domain [BASH], or activation-related B cell
gene [BCA]) is predominantly expressed in B cells (17, 21–
24). In addition, bone marrow macrophages are shown to
express both adaptor molecules (25). The importance of
SLP-76 and BLNK for T and B cell development and sig-
naling has been underscored by gene targeting experiments
in mice and cell lines (26–33). SLP-76 and BLNK are es-
sential for PLC-
 
g
 
 and the subsequent calcium pathway in
T and B cells (28–31).
Although BLNK and SLP-76 share some structural and
functional similarities, differences between BLNK and
SLP-76 have been also documented. For instance, SLP-76
binds to Grb2, Nck, and Vav, whereas BLNK interacts
with PLC-
 
g 
 
in addition to these three molecules. Instead,
in the case of T cells, LAT was shown to bind to PLC-
 
g
 
(for reviews, see references 34, 35). Based on these differ-
ences between SLP-76 and BLNK, together with the evi-
dence that neither LAT nor Gads is expressed in B cells
(12, 13, 18–20), we hypothesized previously that the func-
tions of BLNK are split between SLP-76, Gads, and LAT
(21, 36). To test this hypothesis, we have examined the
BCR functions in Syk
 
2
 
BLNK
 
2
 
 DT40 B cells that carry
various combinations of Zap-70, SLP-76, Gads, and LAT.
Here, we demonstrate that LAT is essential but not suffi-
cient for targeting of SLP-76 to GEMs and its subsequent
functions. In addition to LAT, exogenous expression of
Gads or overexpression of Grb2 was required. Together,
our findings suggest that LAT and a redundant role of Gads
and Grb2 are required for exerting SLP-76 functions.
 
Materials and Methods
 
Expression Constructs, Cells, and Antibodies.
 
Various mutant
chicken DT40 B cells were cultured in RPMI 1640 supple-
 
mented with 10% FCS, 1% chicken serum, 50 
 
m
 
M 2-ME, 4 mM
 
l
 
-glutamine, penicillin, and streptomycin.
Chicken SLP-76 cDNA was isolated by screening chicken thy-
mus cDNA library using human SLP-76 cDNA fragment (17) as a
probe under a low stringent condition. The complete sequence of
the chicken SLP-76 cDNA has been deposited into EMBL/Gen-
Bank/DDBJ under accession no. AF226988. FLAG-tagged
chicken SLP-76 cDNA and membrane SLP-76 chimera cDNA
(mSLP-76; see Fig. 3 A) were constructed by using PCR method
and cloned into expression vector pAzeo. The mSLP-76 is com-
posed of the extracellular domain of human CD16 (amino acids
1–206; reference 37), the transmembrane domain of the mouse
CD45 (amino acids 424–454; reference 38), and the complete
chicken SLP-76 with a FLAG tag at its COOH terminus. FLAG-
tagged chicken BLNK (39), human LAT (13), and human Gads
(18) cDNAs were cloned into pAzeo, pAhygro, and pApuro (40),
respectively. The cDNAs of myc-tagged human Gads and myc-
tagged human Grb2 in pcDNA3.1 were described previously
(18). These cDNAs were transfected by electroporation at 550 V,
25 
 
m
 
F. Expression levels of transfected cDNAs were determined
by Western blot analysis. Cell surface expression of BCR or
CD16 was analyzed by FACScan™ (Becton Dickinson) using
FITC-conjugated anti–chicken IgM Ab (Bethyl) or FITC-conju-
gated anti–human CD16 mAb (BD PharMingen), respectively.
For generation of Syk
 
2
 
BLNK
 
2
 
 DT40 cells (E37-5; see Table
I), the targeting vector pSyk-bsr (40) was transfected into
BLNK
 
2
 
 cells (29). Clones were selected in the presence of 50
 
m
 
g/ml blasticidin S. For isolation of E40-4 and -6 clones, hemag-
glutinin (HA)-tagged human Zap-70 cDNA in pApuro (41) was
transfected into E37-5 cells (see Table I). FLAG-BLNK, FLAG–
SLP-76, or mSLP-76 cDNA was transfected into E40-4 cells,
generating E42-10 and -11, E48-1 and -3, or E77-8 and -9
clones, respectively. LAT, Gads, or both of them were transfected
into E48-1 cells, generating E57-3 and -11, E88-8 and -22, or
E67-1 and -3 clones, respectively. myc-Gads or myc-Grb2
cDNA was transfected into E57-11 cells, generating E61-9 and
-18, or E87-17 and -23 clones, respectively.
Anti–chicken IgM mAb (M4), anti–chicken BLNK Ab, anti–
chicken PLC-
 
g
 
2 Ab, anti–chicken Lyn Ab, anti–human Gads
Ab, anti–human c-Jun NH
 
2
 
-terminal kinase (JNK)1 mAb, an-
tiphosphotyrosine mAb (4G10), anti-myc mAb (9E10), and anti-
FLAG mAb were described previously (18, 29, 39, 42). Anti–
human LAT Ab, anti-HA mAb, anti–human CD16 mAb (3G8),
and anti–
 
a
 
-tubulin mAb were purchased from Upstate Biotech-
nology, Roche, BD PharMingen, and Santa Cruz Biotechnology,
Inc., respectively.
 
Preparation of GEM Fractions.
 
Cells (4 
 
3
 
 10
 
8
 
) were stimulated
with M4 (4 
 
m
 
g/ml) or with anti-CD16 mAb (15 
 
m
 
g/ml) for 3
min in 5 ml RPMI 1640 at 37
 
8
 
C for BCR or mSLP-76 cross-
linking alone, respectively. For coligation of mSLP-76 and BCR
(see Fig. 3 D), E77-9 cells were treated with rabbit anti–mouse
IgM Ab (Zymed Laboratories; 15 
 
m
 
g/ml) for 5 min at 37
 
8
 
C be-
fore stimulation by M4 (4 
 
m
 
g/ml). Cells were washed with PBS
containing 4 mM EDTA, and were resuspended in 1 ml of
TNEV buffer (25 mM Tris-HCl, pH 7.5, 0.5% Triton-X 100,
150 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate)
supplemented with protease and phosphatase inhibitors as de-
scribed previously (40), and were homogenized with 20 strokes
in a loose-fitting dounce homogenizer (Wheaton). The lysates
were gently mixed with 1 ml of 80% (wt/vol) sucrose in TNEV
buffer and placed in the bottom of a centrifuge tube. The samples
were then overlaid with 6.5 ml of 30% sucrose and 3.5 ml of 5%
sucrose in TNEV buffer and supercentrifuged for 16 h at 200,000 
 
g 
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in a RPS40T rotor (Hitachi Instruments) at 4
 
8
 
C. Among 12 frac-
tions collected from the top of the gradient, fraction 4, at the
interface between 5% and 30% sucrose, was confirmed as GEMs
by detecting both ganglioside GM1 and Lyn by Western blot
analysis.
 
Calcium Analysis.
 
Cells (5 
 
3
 
 10
 
6
 
) were suspended in PBS
containing 20 mM Hepes (pH 7.2), 5 mM glucose, 0.025% BSA,
and 1 mM CaCl
 
2
 
, and
 
 
 
were
 
 
 
loaded with 3 
 
m
 
M Fura-2/AM at
37
 
8
 
C for 45 min. Cells were washed twice, adjusted to 10
 
6
 
 cells/
ml, and stimulated by M4 (2 
 
m
 
g/ml). Cross-linking of mSLP-76
alone was performed by anti-CD16 mAb (10 
 
m
 
g/ml), while coli-
gation of BCR and the chimera was carried out by adding rabbit
anti–mouse IgM (10 
 
m
 
g/ml) followed by anti–chicken IgM mAb,
M4 (2 
 
m
 
g/ml). Continuous monitoring of fluorescence from the
cell suspension was performed using Hitachi F-2000 fluorescence
spectrophotometer (Hitachi Instruments) at an excitation wave-
length of 340 nm and an emission wavelength of 510 nm. Cali-
bration and calculation of calcium levels were done as described
(40).
 
Immunoprecipitation, Western Blot Analysis, and In Vitro Kinase
Assay.
 
For immunoprecipitation, cells were solubilized in NP-
40 lysis buffer supplemented with protease and phosphatase in-
hibitors as described previously (40), and precleared lysates were
sequentially incubated with proper Abs and protein G sepharose.
Lysates or immunoprecipitates were separated by SDS-PAGE gel,
transferred to nitrocellulose or polyvinylidene difluoride (PVDF)
membrane, and detected by appropriate Abs and enhanced
chemiluminescence system (Amersham Pharmacia Biotech). For
in vitro kinase assay for JNK, the assay conditions were described
previously (42). Immunoprecipitated JNK1 was suspended in ki-
nase assay buffer in the presence of [
 
g
 
-
 
32
 
P]ATP and glutathione
 
S
 
-transferase (GST)–c-Jun fusion protein as a substrate. The reac-
tion mixtures were separated by 12.5% SDS-PAGE gel, dried,
and subjected to autoradiography.
 
Results
 
SLP-76 Cannot Replace the Function of BLNK in B Cells.
 
Among the Syk family protein tyrosine kinases (PTKs; Syk
and Zap-70), Syk is expressed in B cells, thymocytes, mast
cells, platelets, and neutrophils, whereas Zap-70 expression is
limited to natural killer cells and T cells, including thy-
mocytes (43). When Zap-70 was expressed in Syk
 
2
 
 DT40 B
cells, the early biochemical events, including BCR-induced
tyrosine phosphorylation of cellular proteins, phosphoryla-
tion of Zap-70, and mobilization of intracellular Ca
 
2
 
1
 
 con-
centration
 
 
 
([Ca
 
2
 
1
 
]
 
i
 
), were reconstituted (41). Because BLNK
is essential for BCR-mediated calcium mobilization (29),
these results suggest that BLNK is able to couple Zap-70 as
well as Syk to PLC-
 
g
 
2 activation in B cells. To formally
demonstrate that BLNK is required for Zap-70–mediated
PLC-
 
g
 
2 activation, Syk
 
2
 
BLNK
 
2
 
 
 
DT40 B cells expressing
Zap-70 were generated (E40-4, E40-6). As expected, these
cells failed to evoke BCR-induced PLC-
 
g
 
2 tyrosine phos-
phorylation and the subsequent [Ca
 
2
 
1
 
]
 
i
 
 increase (Fig. 1, A–C).
For a summary of the cell lines and a schematic representa-
tion of the construct used in this study, see Table I and Fig.
3 A. The levels of cell surface expression of BCR in various
clones used in this study were essentially the same as that of
parental DT40 cells.
 
To examine whether SLP-76 can replace the function of
BLNK in B cells, E40-4 cells, which express Zap-70 in
Syk
 
2
 
BLNK
 
2
 
 DT40 B cells, were transfected with chicken
BLNK or chicken SLP-76 cDNA and selected in zeocin-
containing media. For comparison of the expression extent
between BLNK and SLP-76, these cDNAs were tagged
with a FLAG epitope at their NH
 
2
 
 termini. Endogenous
chicken SLP-76 could not be detected by the reverse tran-
scriptase PCR method (data not shown). Among various
stable clones, two independent clones expressing BLNK
(E42-10, E42-11) or SLP-76 (E48-1, E48-3) were estab-
Figure 1. Functional differences between BLNK and SLP-76 in Zap-
701BLNK2 DT40 cells. (A) Expression levels of HA–Zap-70, FLAG-
BLNK, and FLAG–SLP-76 proteins. Whole-cell lysates prepared from 2 3
106 cells were analyzed by Western blotting using anti-HA mAb (left) or
anti-FLAG mAb (right). Lanes: 1, E40-4; 2, E40-6; 3 and 7, E42-10; 4
and 8, E42-11; 5 and 9, E48-1; 6 and 10, E48-3. (B) Calcium mobiliza-
tion analysis. Arrows indicate the time point for adding M4 mAb. (C)
Tyrosine phosphorylation of PLC-g2. At the indicated time points after
M4 stimulation (4 mg/ml), immunoprecipitates with anti–PLC-g2 Ab
(107 cells/lane) were divided in half, separated on a 7% SDS-PAGE gel,
and analyzed by Western blotting with antiphosphotyrosine mAb (top) or
anti–PLC-g2 Ab (bottom). IP, immunoprecipitate. (D) BCR-induced
tyrosine phosphorylation of BLNK and SLP-76. Cells (2 3 106) were
similarly examined as in C using anti-FLAG mAb. Western blotting with
antiphosphotyrosine mAb (top) or anti-FLAG mAb (bottom) is shown.
IP, immunoprecipitate. 
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lished that expressed the comparable levels of BLNK and
SLP-76 (Fig. 1 A), judged by Western blot analysis with
anti-FLAG mAb. In E42-10 and E42-11 clones, the level
of exogenous BLNK expression, detected by using Ab
against chicken BLNK, was almost comparable to that
present in parental DT40 cells (data not shown). In con-
trast to E42-10 and E42-11 clones, BCR-mediated PLC-
 
g
 
2 tyrosine phosphorylation and calcium mobilization
were not reconstituted in E48-1 and E48-3 clones (Fig. 1,
B and C), despite the comparable expression level of SLP-
76 to BLNK. As BLNK
 
2
 
 DT40 cells expressing endoge-
nous Syk and exogenous SLP-76 also failed to evoke the
BCR-mediated calcium mobilization (data not shown), we
conclude that BLNK, but not SLP-76, is able to couple
 
Syk/Zap-70 PTKs to PLC-
 
g
 
2 activation upon BCR
cross-linking.
 
Coligation of Membrane SLP-76 and BCR Restores the
PLC-
 
g
 
2 Activation
 
. To explore the mechanism underlying
the functional difference between BLNK and SLP-76, we
first examined tyrosine phosphorylation status of BLNK
and SLP-76 after BCR ligation. As shown in Fig. 1 D, the
BCR-induced tyrosine phosphorylation of SLP-76 was sig-
nificant, but approximately fourfold lower than that of
BLNK, determined by the ratio of the antiphosphotyrosine
signal to the anti-FLAG signal.
It has been recently shown that BCR and the associated
Ig
 
a
 
 rapidly translocate to GEMs upon receptor cross-link-
ing, which is required for efficient signal transduction by
the BCR (4, 5, 8). We therefore compared translocation of
BLNK and SLP-76 into GEMs upon BCR cross-linking.
After receptor stimulation, DT40 B cells were solubilized
with 0.5% Triton X-100, and lysates were subjected to su-
percentrifiguration over a sucrose density gradient. As re-
ported previously (4, 5), Lyn was enriched in the fraction
4, and tubulin was found to be completely excluded from
the GEMs (Fig. 2). Although the stoichiometry of GEM-
associated BLNK was substantially enhanced after BCR li-
gation, the significant translocation of SLP-76 to the GEMs
could not be detected (Fig. 2). Taken together, these two
lines of findings suggest that the failure of SLP-76 to evoke
PLC-
 
g
 
2 activation in B cells is due to its lower phosphory-
lation and/or its inability to be recruited into GEMs.
If the latter is a major cause, this predicts that the en-
forced localization of SLP-76 in GEMs should rescue the
defect of PLC-
 
g
 
2 activation. To test this prediction, we
have made a membrane chimera of SLP-76 possessing SLP-
76 and CD45 in place of the cytoplasmic and the trans-
Figure 2. Western blot analysis of GEM fractions. After stimulation by
M4 for 3 min, GEMs were prepared from E42-11 or E48-1 cells (4 3
108) by sucrose density gradient centrifugation. 40 ml of the individual
fractions, except for fractions 11 and 12 (2 ml), were analyzed by Western
blotting using anti-FLAG mAb, anti-Lyn Ab, or antitubulin mAb.
Figure 3. GEM-localized SLP-
76 restores PLC-g2 activation.
(A) Schematic diagram of mem-
brane SLP-76 chimera (mSLP-76
[top]). Cell surface expression of
CD16 on transfected cells is
shown in lower panels. Unstained
cells were used as negative con-
trols (dot lines). (B) Calcium mo-
bilization after BCR stimulation,
CD16 cross-linking, or coligation
of BCR to mSLP-76. (C) Ty-
rosine phosphorylation of PLC-
g2. After BCR stimulation,
CD16 cross-linking, or coligation
of BCR to mSLP-76, immuno-
precipitates (107 cells/lane) with
anti–PLC-g2 Ab were divided
into half and analyzed by Western
blotting with 4G10 (top) or anti-
PLC-g2 Ab (bottom). IP, immu-
noprecipitate. (D) Western blot
analysis of GEM fractions. GEMs
were prepared from E77-9 cells
(4 3 108) and analyzed by West-
ern blotting with anti-FLAG
mAb (top) or anti-Lyn Ab (bot-
tom). Among 12 fractions (see
Fig. 2), fraction 4 is shown.851 Ishiai et al.
membrane domains of CD16, respectively (mSLP-76;
shown in Fig. 3 A). It has been reported that CD45 is ex-
cluded from the GEMs (4, 7, 8, 44). Based upon the as-
sumption that the transmembrane domain of CD45 con-
tributes to the exclusion of CD45 from GEMs, this
chimera was designed. The mSLP-76 was introduced into
Syk2BLNK2 DT40 cells expressing Zap-70 (E40-4; Table
I). As expected, significant localization of mSLP-76 into
GEMs was observed only after coligation of BCR and
mSLP-76 (Fig. 3 D). Correlated with this translocation,
only coligation of the BCR to the chimera resulted in a
[Ca21]i increase as well as PLC-g2 tyrosine phosphoryla-
tion (Fig. 3, B and C). Thus, the failure of recruitment of
native SLP-76 into GEMs, wherein the BCR translocates,
likely causes its inability to couple Syk/Zap-70 PTKs to
downstream signaling events such as PLC-g2 activation.
However, we cannot completely exclude the possibility
that the decreased phosphorylation extent of native SLP-76
compared with that of BLNK (Fig. 1 D) could contribute,
at least to some extent, to its inability to mediate down-
stream signaling.
LAT, Gads, and Grb2 Are Involved in Targeting SLP-76
to GEMs. The above results suggest the involvement of
T cell–specific factor(s) in targeting SLP-76 to GEMs,
whereby SLP-76 couples Syk/Zap-70 PTKs to down-
stream effectors. Likely candidates are LAT and/or Gads,
both of which are expressed predominantly in T cells (12,
13, 18–20). Consistent with previous reports, DT40 B cells
express neither LAT nor Gads as detected by Northern blot
analysis or reverse transcriptase PCR method (data not
shown). To examine the requirement for LAT and Gads in
BCR function, E48-1 cells, which express Zap-70 and
SLP-76 in Syk2BLNK2 DT40 cells, were transfected with
various combinations of human LAT and Gads cDNAs and
selected in hygromycin-containing media. Among various
stable transformants, two independent clones were selected
(Table I and Fig. 4). In all clones examined, the expression
levels of LAT and Gads were not significantly greater than
those in Jurkat T cells (data not shown). As observed in hu-
man T cells, two forms of LAT and Gads were recognized
by anti-LAT and anti-Gads Abs, respectively, in transfected
DT40 B cells (12, 13, 19). Fig. 5 A demonstrates that either
LAT or Gads alone was not sufficient to restore BCR-medi-
ated [Ca21]i increase, whereas this calcium defect was re-
stored when both LAT and Gads, in addition to SLP-76,
were introduced.
The calcium data suggest the requirement for both LAT
and Gads, in addition to SLP-76, in BCR-dependent phos-
phorylation of PLC-g2. Expression of LAT was essential
for BCR-mediated tyrosine phosphorylation of PLC-g2,
because DT40 cells lacking LAT (E88-8, E88-22, E48-1,
and E48-3) failed to induce PLC-g2 tyrosine phosphoryla-
tion (Fig. 5 B). In contrast to a complete loss of PLC-g2
tyrosine phosphorylation in DT40 cells lacking LAT, re-
constituted cells by Zap-70, LAT, and SLP-76 (E57-3 and
E57-11) showed the BCR-induced tyrosine phosphoryla-
tion of PLC-g2, although the phosphorylation extent was
approximately threefold lower than that in the completely
reconstituted clones (E67-1 and E67-3). Despite the PLC-
g2 tyrosine phosphorylation, E57-3 and E57-11 clones
failed to induce inositol 1,4,5-trisphosphate (IP3) genera-
tion after BCR stimulation (data not shown), consistent
with the calcium mobilization defect.
As DT40 B cells express Grb2 (42), the above findings
suggest that Gads, but not Grb2, is essential for PLC-g2 ac-
tivation. However, it might be argued that expression level
of endogenous Grb2 is not sufficient for evoking PLC-g2
activation. To examine this possibility, E57-11 cells (ex-
pressing Zap-70, SLP-76, and LAT) were transfected with
human Grb2 or Gads cDNA, both of which were tagged
with a myc-epitope at their NH2 termini. As shown in Fig.
6, the BCR-mediated PLC-g2 activation, judged by its
phosphorylation and calcium mobilization, was reconsti-
tuted in DT40 B cells expressing relatively high levels of
myc-Gads (E61-9) and myc-Grb2 (E87-17). In contrast,
DT40 cells expressing relatively low levels of these tagged
proteins failed to restore the PLC-g2 defect (E61-18 and
E87-23). Based on these data, we conclude that LAT, in
addition to SLP-76, is essential but not sufficient for recon-
stituting the BCR function, and that a redundant function
of Gads and Grb2 is additionally required.
Table I. Expression of BCR and Proteins in DT40 Clones
Clone name BCR
Syk or
Zap-70
BLNK or
SLP-76 LAT
Gads or
Grb2
DT40 (wt) 1 Syk BLNK – –
E37-5 1 –– – –
E40-4, 6 1 Zap-70 – – –
E42-10, 11 1 Zap-70 BLNK – –
E48-1, 3 1 Zap-70 SLP-76 – –
E77-8, 9 1 Zap-70 mSLP-76 – –
E57-3, 11 1 Zap-70 SLP-76 LAT –
E88-8, 22 1 Zap-70 SLP-76 – Gads
E67-1, 3 1 Zap-70 SLP-76 LAT Gads
E61-9, 18 1 Zap-70 SLP-76 LAT myc-Gads
E87-17, 23 1 Zap-70 SLP-76 LAT myc-Grb2
wt, wild-type.
Figure 4. Expression levels of
HA–Zap-70, FLAG–SLP-76,
LAT, and Gads proteins. Total
cell lysates (2.5 3 106 cells) were
prepared and analyzed by West-
ern blotting using anti-HA mAb
(top), anti-FLAG mAb (second
panel), anti-LAT Ab (third
panel), or anti-Gads Ab (bot-
tom), respectively. Lanes: 1,
E67-1; 2, E67-3; 3, E57-3; 4,
E57-11; 5, E88-8; 6, E88-22; 7,
E48-1; 8, E48-3.852 Translocation of SLP-76 to GEMs
As a functional readout of SLP-76, we also examined
whether BCR-mediated JNK activation requires LAT and
Gads, because we had shown previously that not only
PLC-g2 but also JNK activation is dependent on BLNK in
BCR signaling (29). As shown in Fig. 7, SLP-76 was capa-
ble of inducing the BCR-mediated JNK activation in the
presence of both LAT and Gads. As expected, E87-17 cells
expressing LAT and a high level of Grb2 was also capable
of reconstituting the JNK activation (data not shown).
Given the evidence that LAT is palmitoylated and is lo-
calized in GEMs before TCR stimulation (11, 14), the
functional data described above suggest that Gads and Grb2
act as a bridge between LAT and SLP-76, thereby recruit-
ing SLP-76 to GEMs. To test this idea, we first investigated
whether Gads or Grb2 is required for an interaction be-
tween LAT and SLP-76 and the subsequent targeting of
SLP-76 to GEMs. As demonstrated in Fig. 8 A, BCR-
induced association of SLP-76 with LAT was observed
even in the absence of Gads, albeit at a very low level
(E57-11), whereas this association was greatly enhanced by
addition of Gads (E67-3). Similarly, when Grb2 was over-
expressed (E87-17), the BCR-mediated association of
SLP-76 with LAT was significantly enhanced. In contrast
to this inducible association, SLP-76 was constitutively as-
sociated with Gads (E67-3 and E88-8) or Grb2 (E87-17).
As reported, even in the absence of Gads, LAT was consti-
tutively localized in GEMs (Fig. 9 B) and was tyrosine phos-
phorylated by BCR ligation (Fig. 8 B). SLP-76 was slightly
translocated into GEMs even in the absence of Gads. How-
ever, 4.8-fold and 3.1-fold increases in translocation of SLP-76
to GEMs (averages among three independent experiments)
were observed in E67-3 and E87-17 clones, respectively (Fig.
9, A and B). BCR-mediated tyrosine phosphorylation of
SLP-76 appeared to be correlated with the translocation ex-
tent of SLP-76 to GEMs. The SLP-76 phosphorylation was
enhanced z1.5-fold by addition of LAT, and this phosphor-
ylation was further increased about twofold by addition of
Figure 5. Expression of LAT
and Gads in addition to SLP-76
restores PLC-g2 activation in
Zap-701BLNK2 DT40 cells. (A)
Calcium mobilization analysis.
(B) BCR-induced tyrosine phos-
phorylation of PLC-g2. IP, im-
munoprecipitate.
Figure 6. Overexpression of Grb2 replaces the Gads function. (A) Ex-
pression levels of myc-Gads and myc-Grb2 proteins. Total cell lysates (2.5 3
106 cells) were prepared and analyzed by Western blotting using anti-myc
mAb. When anti-Gads Ab was used instead of using anti-myc mAb, two
forms like those described in the legend to Fig. 4 were detected, suggest-
ing that posttranslational modifications, such as cleavage of Gads, might
occur. Lanes: 1, E61-9; 2, E61-18; 3, E87-17; 4, E87-23. (B) BCR-
induced calcium mobilization. (C) Tyrosine phosphorylation of PLC-g2
after BCR engagement. IP, immunoprecipitate.853 Ishiai et al.
BLNK Couples Syk to Downstream Effectors Even in the Ab-
sence of Grb2 and Grap. The above results prompted us to
examine the requirement for Grb2 families, Grb2 and
Grap, in exerting BLNK function. To address this issue, we
monitored calcium mobilization in Grb22Grap2 DT40
cells (45). As shown in Fig. 10 A, these mutant cells still
evoked calcium mobilization, demonstrating that in con-
trast to SLP-76, BLNK still activates PLC-g2 pathway
even in the absence of Grb2 families. Consistent with these
functional data, BLNK was translocated to GEMs even in
the absence of Grb2 and Grap (Fig. 10 B).
Discussion
Functional similarities between the Zap-70 and Syk,
though not identical, have been demonstrated by studies in
many systems. Defects of BCR function in Syk-deficient
DT40 B cells can be restored by the expression of Zap-70
(41). Conversely, expression of Syk in Zap-702/2 mice and
Zap-70–deficient Jurkat T cells results in restoration of thy-
mocyte development and TCR function, respectively (46,
47). In contrast, we report here the inability of SLP-76 to
compensate for the absence of BLNK in the DT40 B cell
line. Expression of SLP-76 in the Zap-701BLNK2 B cells
cannot reconstitute BCR signaling properties as measured
Figure 7. BCR-induced JNK activation. After M4 stimulation, JNK
was immunoprecipitated with anti-JNK1 mAb. Half of immunoprecipi-
tates was used for the in vitro kinase assay (top). The remaining half was
used for Western blotting with anti-JNK1 mAb (bottom).
Figure 8. Association of SLP-76 with LAT, Gads, or Grb2 in DT40
cells. (A) After stimulation by M4 (4 mg/ml) for 3 min, SLP-76 proteins
were immunoprecipitated with anti-FLAG mAb (5 3 107 cells/lane).
Samples were divided, separated on an 8.5% SDS-PAGE gel, and ana-
lyzed by Western blotting with anti-LAT Ab (top), anti-FLAG mAb
(middle), anti-Gads Ab (bottom), or anti-myc mAb (bottom). IP, immu-
noprecipitate. (B) Tyrosine phosphorylation of SLP-76 and LAT. At the
indicated time points after M4 stimulation (4 mg/ml), immunoprecipitates
(2 3 106 cells/lane) with anti-FLAG mAb or anti-LAT Ab were divided
in half, separated on a 9.6% SDS-PAGE gel, and analyzed by Western
blotting with antiphosphotyrosine mAb (top and third panels), anti-FLAG
mAb (second panel), or anti-LAT Ab (bottom). IP, immunoprecipitate.
Figure 9. LAT, Gads, and Grb2 are involved in targeting SLP-76 into
GEM fractions. (A) GEMs were prepared from E67-3 cells (4 3 108) and
analyzed by Western blotting as described in the legend to Fig. 2. (B)
Western blot analyses of GEM fractions (fraction 4) with anti-FLAG mAb
(top), anti-Lyn Ab (middle), and anti-LAT Ab (bottom) are shown.
Gads or Grb2 (Fig. 8 B). Collectively, these results demon-
strate that Gads or Grb2 is involved in the formation of a
complex containing SLP-76 and LAT, and thereby partici-
pating in efficient translocation of SLP-76 to GEMs.854 Translocation of SLP-76 to GEMs
by mobilization of cytoplasmic free calcium and JNK acti-
vation (Fig. 1 and 7).
CD45 is excluded from the GEMs, and this exclusion has
been proposed to be required for efficient antigen receptor
signaling (4, 7, 8, 44). As expected, mSLP-76 harboring the
transmembrane domain of CD45 is not localized in GEMs,
whereas upon coligation of mSLP-76 and BCR, a substan-
tial fraction of the mSLP-76 is enforcedly translocated into
GEMs (Fig. 3 D). In this condition, BLNK-dependent
downstream signaling events such as calcium mobilization
can be reconstituted by SLP-76. Thus, our observations
suggest that SLP-76 possesses a potentiality to couple Zap-
70 to downstream effectors even in the B cell context.
More importantly, together with our evidence that BLNK,
but not native SLP-76, is translocated into GEMs after
BCR ligation, the failure of recruitment of native SLP-76
into GEMs likely causes its inability to couple Zap-70 to
downstream effectors in DT40 B cells. Our conclusion is
further supported by reconstitution experiments using
LAT-deficient Jurkat T cells (J.Cam2; Boerth, N.J., J.J. Sad-
ler, D. Bauer, J.L. Clements, S.M. Gheith, and G.A. Ko-
retzy, manuscript submitted for publication). The defects of
TCR function in the J.Cam2 cells can be restored by intro-
ducing a LAT/SLP-76 chimeric molecule bearing minimal
sequences for targeting LAT to GEMs, demonstrating that
these defects in LAT-deficient cells is presumably due to
the inability of SLP-76 to be recruited to GEMs.
Consistent with important functional roles of LAT in
TCR signaling (12–16, 48), our results demonstrate that
LAT is essential for translocation of SLP-76 to GEMs. In
the absence of LAT, SLP-76 cannot be translocated into
GEMs after BCR ligation. Addition of LAT permits this
translocation, albeit at very low level, even in the absence
of exogenous Gads or Grb2 (Fig. 9 B). The most likely ex-
planation is that LAT uses endogenous Grb2 for targeting
SLP-76 to GEMs in this combination. In support of this
explanation, addition of exogenous Grb2 enhances the
translocation of SLP-76 to GEMs. The SLP-76 transloca-
tion is also augmented by addition of exogenous Gads, sug-
gesting that Grb2 and Gads have a redundant role in trans-
location of SLP-76 to GEMs by bridging between SLP-76
and LAT. Grb2 and Gads, closely related adaptor molecules
containing an SH3-SH2-SH3 motif, form a complex with
LAT and SLP-76 via their SH2 and COOH-terminal SH3
domains, respectively (34, 35). In accord with these bind-
ing data, SLP-76 constitutively and inducibly associates
with Grb2/Gads and phosphorylated LAT, respectively, in
the DT40 B cells.
Although low level of translocation of SLP-76 to GEMs
can be detected even in the absence of exogenous Grb2
and Gads, this level is not sufficient for allowing SLP-76 to
activate downstream events such as calcium mobilization
and JNK activation. Strengthening this idea, expression
levels of Grb2 and Gads proteins were found to correlate
with the ability of SLP-76 to couple to downstream effec-
tors (Fig. 6). Collectively, our results demonstrate that both
LAT and Grb2/Gads are required for sufficient targeting of
SLP-76 to GEMs, wherein SLP-76 is able to activate
downstream effectors. In this regard, it is an intriguing con-
trast that BLNK does not require Grb2/Grap for its target-
ing to GEMs and the subsequent calcium mobilization in
DT40 cells. However, the dispensability of Grb2/Grap in
the BLNK translocation does not eliminate the significance
of Grb2/Grap in BCR signaling. In fact, we have recently
provided the evidence that a redundant role of Grb2 and
Grap is involved in activation of hematopoietic progenitor
kinase (HPK)1, a member of the germinal center kinase
family, in DT40 B cells (45).
Although translocation of BLNK and SLP-76 to GEMs is
essential for propagating antigen receptor signaling, it is not
entirely clear why translocation of BLNK and SLP-76 is re-
quired. This might be accounted for by the requirement for
BLNK/SLP-76 in targeting the associated effector enzymes,
including guanine nucleotide exchange factors Sos and Vav
to GEMs. Because Ras and Rac1 are concentrated in
GEMs (1, 49, 50), recruitment of Sos and Vav to GEMs is
likely to be required for activating Ras and Rac1, leading to
ERK and JNK activation. Indeed, Vav is reported to associ-
ate with SLP-76 and BLNK, whereas Sos binds to Grb2
(34, 35). Assuming that GEMs provide platforms to form
complex multiprotein interactions required for antigen re-
ceptor signaling, the targeting of BLNK/SLP-76 to GEMs
may not be simply to facilitate the localization of various
signaling molecules in GEMs. Rather, after localization of
BLNK/SLP-76 in GEMs, BLNK/SLP-76 may play an im-
portant role in multiprotein complex formation, which in
turn is critical for proper antigen receptor signaling.
Our data indicate that even in the absence of exogenous
Grb2/Gads, PLC-g2 is phosphorylated to some extent, but
not activated as determined by IP3 generation and calcium
mobilization. Because translocation of PLC-g to GEMs is
essential for its tyrosine phosphorylation and the subse-
quent activation in antigen receptor signaling (5, 7, 11),
one explanation for this result is that the amount of tar-
Figure 10. BLNK is translocated to GEMs in the absence of Grb2 and
Grap in B cells. (A) Calcium mobilization in wild-type and Grb22Grap2
DT40 cells. (B) Western blot analyses of GEM fractions (fraction 4) are
shown. BLNK and Lyn were determined by Western blotting with anti-
BLNK Ab (top) or anti-Lyn Ab (bottom).855 Ishiai et al.
geted PLC-g2 to GEMs is small, like low level of translo-
cation of SLP-76 to GEMs in the absence of exogenous
Grb2/Gads, likely causing inefficient PLC-g2 activation.
In this regard, our IP3 and calcium assay systems might not
be sensitive enough to detect subtle PLC-g2 activation. A
second possibility is that Btk dysfunction is responsible for
the low level of PLC-g2 phosphorylation and the resulting
lack of its activation, because similar PLC-g2 abnormality
is also observed in Btk-deficient DT40 B cells (40). Given
that Btk associates with phosphorylated BLNK and SLP-76
via its SH2 domain (39, 51), sufficient recruitment of SLP-
76 to GEMs might be required for targeting Btk to GEMs,
thereby phosphorylating PLC-g2. These two possibilities
are not mutually exclusive.
Our evidence that SLP-76 and BLNK use distinct adap-
tor molecules for their targeting to GEMs raises questions
about the translocation mechanism of BLNK after BCR li-
gation. On the analogy of the T cell system, one obvious
possibility is that a LAT-like molecule constitutively local-
ized in GEMs plays a role in targeting BLNK to GEMs in
B cells. In contrast to requirement for Grb2/Gads in target-
ing SLP-76 to GEMs, BLNK can be translocated to GEMs
even in the absence of Grb2, Grap, and Gads. Thus, not
only a LAT-like molecule but also a Grb2-like molecule
that is specifically expressed in B cells might exist. The op-
posite possibility is that BLNK does not require these adap-
tor molecules for its targeting to GEMs in B cells. For in-
stance, direct binding of BLNK with Syk or Iga/Igb may
be sufficient for its targeting.
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